CHA News Article

HRSA Releases New Findings for 340B Program
Will host recertification webinar tomorrow

New findings from the Health Resources and Services Administration (HRSA) for the 340B Drug Pricing Program show adverse audit findings for only four of 19 covered entities. HRSA’s Office of Pharmacy Affairs conducted the audits in fiscal year 2013 and will update corrective action plans and sanctions once approved by HRSA. Until the corrective action plans are posted on the HRSA website, manufacturers are advised not to contact audited entities about sanctions. To help hospitals with 340B recertification, the Office of Pharmacy Affairs will host a webinar tomorrow, June 26 at 11 a.m. (PT). Hospital leaders can join the meeting here and access the call-in line at (888) 950-6750 (participant code 8501607). Providers who cannot participate in the webinar will be able to access a replay at